|Articles|November 27, 2021

First of a New Class of Drugs to Treat Early-Stage Triple-Negative Breast Cancer Approved

A promising new drug for treating this type of breast cancers in its early stages may help prevent the return of cancer.

Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer with limited treatment options. A promising new drug for treating this type of breast cancers in its early stages may help prevent the return of cancer. Read more in our XRAY review. #helpnothype #BehindtheCancerHeadlines

https://www.facingourrisk.org/XRAY/pembrolizumab-for-triple-negative-breast-cancer?utm_source=CURE&utm_medium=website&utm_campaign=organic_social_website

Stay up to date on cancer updates, research and education

First of a New Class of Drugs to Treat Early-Stage Triple-Negative Breast Cancer Approved

Trending on CURE

The First-Ever Personalized Cancer Vaccine to Pass a Phase 3 Trial Just Beat Keytruda Alone

"Lung Cancer Made Me Who I Am Today” : Juanita Segura on Her Journey and Finding Hope

She Was the One Everyone Counted On: When a Mother and Wife Gets Cancer

When Cancer Diagnoses Lead to Guilt

Keytruda Plus Xgeva Shrank Tumors in 31% of Patients With Clear Cell Kidney Cancer